Nanobac Pharmaceuticals Financial Statements
Nanobac Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
Nanobac Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.2 | 0.7 |
| Gross Profit ($ mil.) | 0.0 | 0.2 | 0.4 |
| Operating Income ($ mil.) | (4.9) | (4.8) | (2.8) |
| Total Net Income ($ mil.) | (6.6) | (5.0) | (3.7) |
| Diluted EPS (Net Income) | (0.03) | (0.02) | (0.02) |
Nanobac Pharmaceuticals Stock Quote & Chart
| 12/02/08 12:30:39 EST •
Nasdaq Other OTC •
0.01
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Nanobac Pharmaceuticals Competitive Intelligence
| Abbott Labs | Johnson & Johnson | Roche Diagnostics | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 61,095.0 | 215.1 |
| Employees | 68,000 | 119,200 | 2,000 |
| Market Cap ($ mil.) | 90,488.8 | 198,797.7 | -- |





